NCT03469830

Brief Summary

This study explores the smart scar care pad's potential therapeutic effect in treatment hypertrophic scar while elucidating the adverse effects if there is any. Half of the participant receives traditional treatment of pressure garment and the other half receives the smart scar care pad together with pressure garment.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

March 13, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 19, 2018

Completed
Last Updated

March 29, 2018

Status Verified

March 1, 2018

Enrollment Period

1 year

First QC Date

March 13, 2018

Last Update Submit

March 27, 2018

Conditions

Keywords

insertpressure therapysilicone gel

Outcome Measures

Primary Outcomes (1)

  • Change of Scar Pliability measured by the DermaLab Combo

    Scar pliability is represented by the Young's modulus measured by the elasticity measurement of the DermaLab Combo

    baseline and 6 weeks

Secondary Outcomes (6)

  • Change of Scar Thickness measured by the diagnostic ultrasound system

    baseline and 6 weeks

  • Change of Scar Pigmentation measured by the DermaLab Combo

    baseline and 6 weeks

  • Change of Scar Vascularity measured by the DermaLab Combo

    baseline and 6 weeks

  • Occurrence of blistering

    up to 6 weeks

  • Occurrence of skin breakdown

    up to 6 weeks

  • +1 more secondary outcomes

Study Arms (2)

SSCP & SPMS

EXPERIMENTAL

The smart scar care pad (SCCP): The SCCP is a newly invented insert material that can maximise treatment outcomes via enhanced compression and occlusion. The wearing regime for SCCP is 4 hours a day for the first day, with 2-hour increments added every other day until the total wearing time reached 23 hours. SSCP was cleaned twice a day for hygienic reasons. The smart pressure monitored suit(SPMS): The SPMS is a type of custom-made pressure garment. SPMS was used 23 hours a day and only removed when showering.

Other: SSCPOther: SPMS

SPMS

ACTIVE COMPARATOR

The smart pressure monitored suit(SPMS): The SPMS is a type of custom-made pressure garment. SPMS was used 23 hours a day and only removed when showering.

Other: SPMS

Interventions

SSCPOTHER

Insert

Also known as: The Smart Scar Care PAd
SSCP & SPMS
SPMSOTHER

Pressure therapy

Also known as: The Smart Pressure Monitored Suit
SPMSSSCP & SPMS

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects with Hypertrophic Scar(HS);
  • the HS had a total Vancouver Scar Scale (VSS) score of 4 or higher and the score of each item equal to or greater than 1;
  • subjects age between 20 and 70 years, cooperative, and good compliance with treatment.

You may not qualify if:

  • the HS area had an open wound or infection;
  • the HS had been treated with steroid injections or other intervention (such as traditional Chinese medicine or laser therapy) before the study; or
  • the patient had a medical condition that might affect wound healing (e.g., diabetes mellitus or another serious medical problem).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cicatrix, Hypertrophic

Interventions

Polymorphism, Single-Stranded Conformational

Condition Hierarchy (Ancestors)

CicatrixFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Polymorphism, GeneticGenetic VariationGenetic Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The subjects and the analyser of the data were blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2018

First Posted

March 19, 2018

Study Start

November 1, 2015

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

March 29, 2018

Record last verified: 2018-03